Aspirin Effectiveness and its Influence on Cardiovascular Risk

Speaker Name/Credentials

Jeffrey Boone, M.D.
Founder and Director of the Boone Heart Institute

Estimated Time of Talk

45 minutes


This webinar will cover clinical implications and therapeutic approaches to patients who are poor responders to aspirin therapy.

Learning Objectives

  1. Learn how aspirin therapy reduces cardiovascular events.
  2. Review how 11-dhTXB2 levels can indicate aspirin effectiveness.
  3. Therapeutic considerations and additional testing for those who are poor responders to aspirin therapy.

Conflicts of Interest

Speaker- Amgen, Aralez, Cleveland HeartLab

Share this: